These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report. Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532 [TBL] [Abstract][Full Text] [Related]
4. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients? Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951 [TBL] [Abstract][Full Text] [Related]
5. [Nephrogenic systemic fibrosis and use of MR contrast media]. Christiansen RE; Sviland L; Sekse I; Svarstad E Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161 [TBL] [Abstract][Full Text] [Related]
6. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456 [TBL] [Abstract][Full Text] [Related]
7. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784 [TBL] [Abstract][Full Text] [Related]
8. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review. Sanyal S; Marckmann P; Scherer S; Abraham JL Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397 [TBL] [Abstract][Full Text] [Related]
9. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan. Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369 [TBL] [Abstract][Full Text] [Related]
10. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485 [TBL] [Abstract][Full Text] [Related]
12. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure. Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease. Heinz-Peer G; Neruda A; Watschinger B; Vychytil A; Geusau A; Haumer M; Weber M Eur J Radiol; 2010 Oct; 76(1):129-34. PubMed ID: 19619969 [TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis: history and epidemiology. Thomsen HS Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597 [TBL] [Abstract][Full Text] [Related]
15. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis. Hendriks MP; de Sévaux RG; Hilbrands LB Neth J Med; 2008; 66(7):269-74. PubMed ID: 18663253 [TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006. Kendrick-Jones JC; Voss DM; De Zoysa JR Nephrology (Carlton); 2011 Feb; 16(2):243-8. PubMed ID: 21272139 [TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis following gadolinium administration. Tammaro A; Narcisi A; Tuchinda P; Sina B Cutis; 2015 Jul; 96(1):E23-5. PubMed ID: 26244362 [No Abstract] [Full Text] [Related]
18. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide. Steger-Hartmann T; Raschke M; Riefke B; Pietsch H; Sieber MA; Walter J Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226 [TBL] [Abstract][Full Text] [Related]
19. Safety of older generations of gadolinium in mild-to-moderate renal failure. Khatami SM; Mahmoodian M; Zare E; Pashang M Ren Fail; 2012; 34(2):176-80. PubMed ID: 22260266 [TBL] [Abstract][Full Text] [Related]